Eric Guyer - 15 Mar 2024 Form 4 Insider Report for EXPONENT INC (EXPO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Mar 2024, 20:24:07 UTC
Prior SEC filing
15 Mar 2024
Next SEC filing
30 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Wendy Whitehouse For: Eric Guyer

Key filing fact

Eric Guyer filed Form 4 for EXPONENT INC (EXPO) on 19 Mar 2024.

Key facts

  • This page summarizes Eric Guyer's Form 4 filing for EXPONENT INC (EXPO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 19 Mar 2024, 20:24.

Change

  • Previous filing in this sequence was filed on 15 Mar 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXPO transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+8,084
Change %
Price
Shares after
8,084
Date
15 Mar 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,084
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

1-for-1.

Footnote F2

Not applicable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .